Transforming growth factor-β (TGF-β)-signaling and TGF-β-mediated epithelial-mesenchymal transition (EMT) were recently shown to induce sorafenib resistance by induction of receptor tyrosine kinases and stemness features in HCC cells [34]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.